A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Zanubrutinib
Related studies linked through entity extraction aliases.
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT
- Status
- RECRUITING
- Phase
- PHASE2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
- Status
- UNKNOWN
- Phase
- PHASE2
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- N/A
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Relative Bioavailability of Zanubrutinib Tablets Compared to Capsules and Effects of Food on the Pharmacokinetics of the Tablet in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2